查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1358085

糖尿病足潰瘍治療市場：依產品、依潰瘍類型、依最終用戶、依地區

Diabetic Foot Ulcers Treatment Market, By Product, By Ulcer Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 188 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2023 年，全球糖尿病足潰瘍治療市場規模將達到 77.2 億美元，預測期內（2023-2030 年）年複合成長率為 10.2%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 77.2億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 10.20% 2030年市場規模預測 152.1億美元
糖尿病足潰瘍治療的全球市場佔有率(%) （依產品），2023 年
糖尿病足潰瘍治療市場-IMG1

糖尿病足潰瘍是糖尿病控制不佳的患者最常見的併發症之一。它通常是由血糖控制不良、潛在的神經病變、末稍血管疾病或足部護理不良所引起。它也是足部骨髓炎和下肢截肢的最常見原因之一。這些潰瘍通常發生在經歷重複性創傷或壓力感的足部區域。該疾病通常是慢性的，跨專業的方法可以產生最好的結果。足病診療師、內分泌科醫生、基層醫療醫師、血管外科醫生和感染疾病專家的共同參與是極為有益的。這是門診和住院時常遇到的情況。因此，預計市場上新技術的引入將在預測期內推動全球糖尿病足潰瘍治療市場的成長。

市場動態

醫療產業的主要參與者和研究機構專注於開發用於各種治療程序的技術進步、藥物、設備和系統。因此，在市場上引入此類先進產品預計將在預測期內推動全球糖尿病足潰瘍治療市場的成長。例如，2023年7月27日，貝爾法斯特女王大學的研究人員設計了一種被稱為支架的新型3D列印繃帶，提出了一種治癒糖尿病足潰瘍（DFU）的創新治療方法。這項新發現將脂質奈米粒子和水凝膠結合起來，創造出個人化的類皮膚 3D 列印支架。該支架結合了大量釋放和持續釋放含抗生素分子的能力，可治療糖尿病潰瘍。

本研究的主要特點

  • 本報告詳細分析了全球糖尿病足潰瘍治療市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率(CAGR)。它揭示了各個部門市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球糖尿病足潰瘍治療市場的主要企業。
  • 該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
  • 全球糖尿病足潰瘍治療市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球糖尿病足潰瘍治療市場的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
  • 影響分析
  • 最近測試啟動
  • 流行病學
  • 合併、收購和合作
  • 法規場景
  • 主要進展
  • PEST分析

第4章 全球糖尿病足潰瘍治療市場-新型冠狀病毒感染疾病（COVID-19）的影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 對需求和供給的影響

第5章 全球糖尿病足潰瘍治療市場，依產品，2018-2030

  • 先進的傷口敷料
  • 皮膚替代
  • 生長因子
  • 負壓傷口護理儀
  • 其他

第6章 全球糖尿病足潰瘍治療市場，依潰瘍類型，2018-2030

  • 神經病變潰瘍
  • 缺血性潰瘍
  • 神經缺血性潰瘍

第7章 全球糖尿病足潰瘍治療市場，依最終用戶分類，2018-2030 年

  • 醫院
  • 專科診所
  • 長期照護中心
  • 門診手術中心

第8章 2018-2030年全球糖尿病足潰瘍治療市場（依地區）

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • 公司簡介
    • 3M Healthcare
    • Braun Melsungen AG
    • Smith &Nephew, Inc.
    • Organogenesis, Inc.
    • Derma Sciences Inc.
    • Sigvaris Inc.
    • Acelity LP Inc.
    • Osiris
    • Molnlycke Health Care AB
    • Alkem Laboratories Ltd.
    • Healthium Medtech
    • Kerecis
    • Podimetrics
    • Carmell Corporation
    • Paracrine, Inc.
    • VIVEX Biologics, Inc.
    • PolarityTE, Inc.

第10章 章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1357

The global diabetic foot ulcers treatment market is estimated to be valued at US$ 7.72 Bn in 2023 and is expected to exhibit a CAGR of 10.2% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 7.72 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.20% 2030 Value Projection: US$ 15.21 Bn
Global Diabetic Foot Ulcers Treatment Market Share (%), By Product, 2023
Diabetic Foot Ulcers Treatment Market - IMG1

Diabetic foot ulcers are among the most common complications in patients with diabetes mellitus, which is not well controlled. It is usually the result of poor glycemic control, underlying neuropathy, peripheral vascular disease, or poor foot care. It is also one of the most common causes of osteomyelitis of the foot and amputation of the lower extremities. These ulcers are usually in areas of the foot that encounter repetitive trauma and pressure sensations. The disease is typically chronic, and an interprofessional approach will have the best outcome. The combined involvement of a podiatrist, endocrinologist, primary care physician, vascular surgeon, and infectious disease specialist is extremely beneficial. It is a commonly encountered scenario in both outpatient and inpatients settings. Thus, the introduction of new technology in the market is expected to drive the growth of the global diabetic foot ulcers treatment market over the forecast period.

Market Dynamics

The key players and the research institutes in the medical industry are focusing on the development of technological advancements, drugs and instruments, and systems for various treatment procedures. Thus, the introduction of such advanced products in the market is expected to drive growth of the global diabetic foot ulcers treatment market over the forecast period. For instance, on July 27, 2023, researchers from Queen's University Belfast designed a new 3D-printed bandage known as a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs). The new discovery combines lipid nanoparticles and hydrogels, which are used to create personalized, skin-like 3D-printed scaffolds. These scaffolds have the ability to release both a bulk and sustained release of antibiotic-loaded molecules to treat diabetic ulcers.

Key features of the study:

  • This report provides an in-depth analysis of the global diabetic foot ulcers treatment market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global diabetic foot ulcers treatment market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include 3M Healthcare, Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, Molnlycke Health Care AB, Alkem Laboratories Ltd., Healthium Medtech, Kerecis, Podimetrics, Carmell Corporation, Paracrine, Inc., VIVEX Biologics, Inc., and PolarityTE, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global diabetic foot ulcers treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetic foot ulcers treatment market.

Detailed Segmentation:

  • By Product:
    • Advance Wound Dressings
    • Skin Substitutes
    • Growth Factors
    • Negative Pressure Wound Therapy Devices
    • Other Devices
  • By Ulcer Type:
    • Neuropathic Ulcers
    • Ischemic Ulcers
    • Neuro-ischemic Ulcers
  • By End User:
    • Hospital
    • Specialty Clinics
    • Long Term Care Centers
    • Ambulatory Surgical Centers
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • 3M Healthcare
    • Braun Melsungen AG
    • Smith & Nephew, Inc.
    • Organogenesis, Inc.
    • Derma Sciences Inc.
    • Sigvaris Inc.
    • Acelity L.P. Inc.
    • Osiris
    • Molnlycke Health Care AB
    • Alkem Laboratories Ltd.
    • Healthium Medtech
    • Kerecis
    • Podimetrics
    • Carmell Corporation
    • Paracrine, Inc.
    • VIVEX Biologics, Inc.
    • PolarityTE, Inc.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Ulcer Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Diabetic Foot Ulcers Treatment Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Diabetic Foot Ulcers Treatment Market, By Product, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Advance Wound Dressings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Skin Substitutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Growth Factors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Negative Pressure Wound Therapy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Other Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

6. Global Diabetic Foot Ulcers Treatment Market, By Ulcer Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Neuropathic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Neuro-ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

7. Global Diabetic Foot Ulcers Treatment Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Long Term Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

8. Global Diabetic Foot Ulcers Treatment Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • 3M Healthcare*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Braun Melsungen AG
    • Smith & Nephew, Inc.
    • Organogenesis, Inc.
    • Derma Sciences Inc.
    • Sigvaris Inc.
    • Acelity L.P. Inc.
    • Osiris
    • Molnlycke Health Care AB
    • Alkem Laboratories Ltd.
    • Healthium Medtech
    • Kerecis
    • Podimetrics
    • Carmell Corporation
    • Paracrine, Inc.
    • VIVEX Biologics, Inc.
    • PolarityTE, Inc.

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact